weight loss drug news today glp-1 Half of users ditch their injections — and some are turning to other weight-loss methods instead Brain scientists are seeking weight-loss

Cost and Accessibility: New drugs often come with high price tags, and access can be limited by insurance coverage and healthcare policies

Data from the Centers for Disease Control and Prevention (CDC) in 2023 indicated that more than 37 million adults in the United States were living with diabetes, while obesity rates remained considerably high across the region

(2021) showed that the GLP-1 RA drug class may be associated with a relative risk reduction for clinical kidney outcomes of 21% (HR 0.79

Resmetirom is generally well tolerated

2022Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes

[DOI] [PubMed] [Google Scholar] 66.Zhao H-J, Jiang X, Hu L-J, Yang L, Deng L-D, Wang Y-P, et al